European commission official hits back at US criticism of EU reg system
This article was originally published in Clinica
The European Commission has asked US regulators for evidence to back derogatory remarks about the EU regulatory system made by Jeff Shuren, director of the US FDA's Center for Devices and Radiological Health. These comments were made when, apparently backed into a corner while trying to defend his own medtech policies, Dr Shuren accused the EU of treating its patients as rodents in medical experiments (www.clinica.co.uk, 25 January 2011).
You may also be interested in...
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.
2020 is not getting off to a good start for manufacturers needing to comply with the EU’s new Medical Device Regulation on 26 May 2020. The European Commission’s latest document seems to confirm industry’s fears about the ability of the EU’s medtech system to be ready in time.
December 2019 was a big month for far-reaching EU medtech regulatory developments that will have a significant impact on the way and speed of implementation of the Medical Device Regulation.